Headed by Daniel Drucker, MD, a senior investigator at the Lunenfeld-Tanenbaum Research Institute, the team reported on their findings in Cell Metabolism , in a paper titled The weight-loss-independent hepatoprotective benefits of semaglutide are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors. For years, the liver benefits of semaglutide have puzzled scientists
Compounded meds are not inspected by the FDA, and that lack of quality control means they pose some level of risk, including incorrect dosing, contamination, and the use of expired ingredients
Why it matters for MT-2: Case reports document blood pressure increases, flushing, and sympathomimetic-like symptoms with MT-2 use
About this article Cite this article Angelopoulos, N., Androulakis, I., Rizoulis, A